Bacterial vaginosis: A problematic infection from both a perinatal and neonatal perspective

Seminars in Fetal and Neonatal Medicine

Volumn 14, Issue 4, 2009, Pages 200-203

  Denney, Jeff M ^a   Culhane, Jennifer F ^b  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

Bacterial vaginosis; Morbitity; Mortality; Pregnancy

Indexed keywords

CLINDAMYCIN; CLOTRIMAZOLE; ERYTHROMYCIN; METRONIDAZOLE;

ADVERSE OUTCOME; ARTICLE; BEHAVIOR; BIOLOGY; CHORIOAMNIONITIS; COLOR; ENDOMETRITIS; ENVIRONMENT; GENE; GENITAL TRACT INFECTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; INFLAMMATION; MORBIDITY; MORTALITY; MOTHER; NEWBORN PERIOD; OUTCOME ASSESSMENT; PATHOLOGY; PERINATAL PERIOD; PHYSIOLOGY; PRACTICE GUIDELINE; PREGNANCY; PREMATURE FETUS MEMBRANE RUPTURE; PREMATURE LABOR; RISK; SCREENING; SPONTANEOUS ABORTION; VAGINA DISCHARGE; VAGINAL PRURITUS; VAGINITIS;

CHORIOAMNIONITIS; FEMALE; HUMANS; OBSTETRIC LABOR, PREMATURE; PERINATAL CARE; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREGNANCY OUTCOME; PRENATAL DIAGNOSIS; VAGINOSIS, BACTERIAL;

EID: 67349266667     PISSN: 1744165X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.siny.2009.01.008     Document Type: Article

References (53)

1. Colli E., Bertulessi C., Landoni M., and Parazzini F. Bacterial vaginosis in pregnancy and preterm birth: evidence from the literature. J Int Med Res 24 (1996) 317-324
2. Shanon H. Diagnostic microbiology of bacterial vaginosis. Am J Obstet Gynecol 165 (1993) 1240-1244
3. Carey J.C., Klebanoff M.A., Hauth J.C., et al. Metronidazole to prevent preterm delivery in pregnant women with asymptomatic bacterial vaginosis. N Engl J Med 342 (2000) 534-540
4. Simoes J.A., Giraldo P.C., and Faundes A. Prevalence of cervicovaginal infections during gestation and accuracy of clinical diagnosis. Infect Dis Obstet Gynecol 6 (1998) 129-133
5. Amsel R., Totten P.A., Spiegel C.A., Chen K.C., Eschenbach D., and Holmes K.K. Nonspecific vaginitis. Diagnostic criteria and microbial and epidemiologic associations. Am J Med 74 (1983) 14-22
6. Hillier S.L. Diagnostic microbiology of bacterial vaginosis. Am J Obstet Gynecol 169 (1993) 455-459
7. Nugent R.P., Krohn M.A., and Hillier S.L. Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation. J Clin Microbiol 29 (1991) 297-301
8. Lamont R.F., Anthony F., Myatt L., Booth L., Furr P.M., and Taylor-Robinson D. Production of prostaglandin E2 by human amnion in vitro in response to addition of media conditioned by microorganisms associated with chorioamnionitis and preterm labor. Am J Obstet Gynecol 162 (1990) 819-825
9. Donders G.G., Van Bulck B., Caudron J., Londers L., Vereecken A., and Spitz B. Relationship of bacterial vaginosis and mycoplasmas to the risk of spontaneous abortion. Am J Obstet Gynecol 183 (2000) 431-437
10. Roy S. Nonbarrier contraceptives and vaginitis and vaginosis. Am J Obstet Gynecol 165 (1991) 1240-1244
11. Gravett M.G., Hitti J., Hess D.L., and Eschenbach D.A. Intrauterine infection and preterm delivery: evidence for activation of the fetal hypothalamic-pituitary-adrenal axis. Am J Obstet Gynecol 182 (2000) 1404-1413
12. Goldenberg R.L., Hauth J.C., and Andrews W.W. Intrauterine infection and preterm delivery. N Engl J Med 342 (2000) 1500-1507
13. Guaschino S., De Seta F., Piccoli M., Maso G., and Alberico S. Aetiology of preterm labour: bacterial vaginosis. Br J Obstet Gynaecol 113 Suppl. 3 (2006) 46-51
14. Hay P.E., Lamont R.F., Taylor-Robinson D., Morgan D.J., Ison C., and Pearson J. Abnormal bacterial colonisation of the genital tract and subsequent preterm delivery and late miscarriage. Br Med J 308 (1994) 295
15. Gravett M.G., Nelson H.P., DeRouen T., Critchlow C., Eschenbach D.A., and Holmes K.K. Independent associations of bacterial vaginosis and Chlamydia trachomatis infection with adverse pregnancy outcome. J Am Med Assoc 256 (1986) 1899
16. Hill G.B. Preterm birth: associations with genital and possibly oral microflora. Ann Periodontol 3 (1998) 222
17. Kurki T., Sivonen A., Renkonen O.V., Savia E., and Ylikorkala O. Bacterial vaginosis in early pregnancy and pregnancy outcome. Obstet Gynecol 168 (1993) 514-519
18. Nejad V.M., and Shafaie S. The association of bacterial vaginosis and preterm labor. J Pak Med Assoc 58 (2008) 104-106
19. Hillier S.L., Martius J., Krohn M., Kiviat N., Holmes K.K., and Eschenbach D.A. A case-control study of chorioamnionic infection and histologic chorioamnionitis in prematurity. N Engl J Med 319 (1988) 972-978
20. Hauth J.C., Andrews W.W., and Goldenberg R.L. Infection-related risk factors predictive of spontaneous preterm labor and birth. Prenat Neonatal Med 3 (1998) 86-90
21. Romero R., Espinoza J., Gotsch F., et al. The use of high dimensional biology (genomics, transcriptomics, proteomics and metabolomics) to understand the preterm parturition syndrome. Br J Obstet Gynaecol 113 S3 (2006) 118
22. Popko B., Corbin J.G., Baerwald K.D., Dupree J., and Garcia A.M. The effects of interferon-gamma on the central nervous system. Mol Neurobiol 14 (1997) 19
23. Yoon B.H., Romero R., Jun J.K., et al. Amniotic fluid cytokines (interleukin-6, tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-8) and the risk for the development of bronchopulmonary dysplasia. Am J Obstet Gynecol 177 (1997) 825
24. Yoon B.H., Romero R., Yang S.H., et al. Interleukin-6 concentrations in umbilical cord plasma are elevated in neonates with white matter lesions associated with periventricular leukomalacia. Am J Obstet Gynecol 174 (1996) 1433
25. Yoon B.H., Romero R., Park J.S., et al. Fetal exposure to an intra-amniotic inflammation and the development of cerebral palsy at the age of three years. Am J Obstet Gynecol 182 (2000) 675
26. Nelson D.B., Bellamy S., Nachamkin I., Ruffin A., Taylor L.A., and Friedenberg F.K. Characteristics and pregnancy outcomes of pregnant women asymptomatic for bacterial vaginosis. Matern Child Health J 12 (2008) 216-222
27. Nygren P., Fu R., Freeman M., Bougatsos C., Klebanoff M., and Guise J. Evidence on the benefits and harms of screening and treating pregnant women who are asymtomatic for bacterial vaginosis: an update review for the U.S. Preventive Services Task Force. Ann Intern Med 148 (2008) 220-233
28. Koumans E.H., Markowitz L.E., Hogan V., and for the CDC BV Working Group. Indications for therapy and treatment recommendations for bacterial vaginosis in nonpregnant and pregnant women: a synthesis of data. Clin Infect Dis 35 Suppl. 2 (2002) S152-S172
29. Myer L., Denny L., Telerant R., et al. Bacterial vaginosis and susceptibility to HIV infection in South African women: a nested case-control study. J Infect Dis 192 (2005) 1372-1380
30. Cu-Uvin S., Hogan J., Caliendo A.M., et al., Study for the HIV Epidemiology Research. Association between bacterial vaginosis and expression of human immunodeficiency virus type I RNA in the female genital tract. Clin Infect Dis 33 (2001) 894-896
31. Cohn J.A., Hahemi F.B., Camarca, et al. HIV-inducing factor in cervicovaginal secretions is associated with bacterial vaginosis in HIV-1-infected women. J Acquir Immune Defic Syndr 39 (2005) 340-346
32. Martin H.L., Richardson B.A., Nyange P.M., et al. Vaginal lactobacilli, microbial flora, and risk of human immunodeficiency virus type 1 and sexually transmitted disease acquisition. J Infect Dis 180 (1999) 1863-1868
33. Cherpes T.L., Meyn L.A., Krohn M.A., et al. Association between acquisition of herpes simplex virus type 2 in women and bacterial vaginosis. Clin Infect Dis 37 (2003) 319-325
34. Daskalakis G., Papapanagiotou A., Mesogitis S., et al. Bacterial vaginosis and Group B Streptococcal colonization and preterm delivery in a low-risk population. Fetal Diagn Ther 21 (2006) 172-176
35. Vallor A.C., Antonio M.A., Hawes S.E., and Hillier S.L. Factors associated with acquisition of, or persistent colonization by, vaginal lactobacilli: role of hydrogen peroxide production. J Infect Dis 184 (2001) 1431-1436
36. Allsworth J.E., and Peipert J.F. Prevalence of bacterial vaginosis: 2001-2004 National Health and Nutrition Examination Survey data. Obstet Gynecol 109 (2007) 114-120
37. Simhan H.N., Bodnar L.M., and Krohn M.A. Paternal race and bacterial vaginosis during the first trimester of pregnancy. Am J Obstet Gynecol 198 (2008) 196.e1-196.e4
38. Koumans E.H., Sternberg M., Bruce C., et al. The prevalence of bacterial vaginosis in the United States, 2001-2004; Associations with symptoms, sexual behaviors, and reproductive health. Sex Transm Dis 34 (2007) 864-869
39. Hassan W., Lavreys L., Chohan V., et al. Associations between intravaginal practices and bacterial vaginosis in Kenyan female sex workers without symptoms of vaginal infections. Sex Transm Dis 34 (2007) 384-388
40. Marrazzo J.M., Koutsky L.A., Eschenbach D.A., et al. Characterization of vaginal flora and bacterial vaginosis in women who have sex with women. J Infect Dis 185 (2002) 1307-1313
41. Lamont R.F. Can antibiotics prevent preterm birth - the pro and con debate. Br J Obstet Gynaecol 112 (2005) 67
42. Pretorius C., Jaggatt A., and Lamont R.F. The relationship between periodontal disease, bacterial vaginosis, and preterm birth. J Perinat Med 35 (2007) 93-99
43. Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines: management of patients who have vaginal infections. Available from:. http://www.cdc.gov/STD/treatment (accessed September 30, 2008)
44. Beigi R.H., Austin M.N., Meyn L.A., Krohn M.A., and Hillier S.L. Antimicrobial resistance associated with the treatment of bacterial vaginosis. Am J Obstet Gynecol 191 (2004) 1124-1129
45. Morales W.J., Schorr S., and Albritton J. Effect of metronidazole in patients with preterm birth in preceding pregnancy and bacterial vaginosis: a placebo-controlled double-blind study. Am J Obstet Gynecol 171 (1994) 345-347
46. Hauth J.C., Goldenberg R.L., Andrews W.W., DuBard M.B., and Cooper R.L. Reduced incidence of preterm delivery with metronidazole and erythromycin in women with bacterial vaginosis. N Engl J Med 173 (1995) 1527-1531
47. McDonald H.M., O'Loughlin J.A., Vigneswaren R., et al. Impact of metronidazole therapy on preterm birth in women with bacterial vaginosis flora (Gardnerella vaginalis): a randomized, placebo controlled trial. Br J Obstet Gynaecol 104 (1997) 1391-1397
48. Lamont R., Duncan S., Mandal D., and Basset P. Intravaginal clindamycin to reduce preterm birth in women with abnormal genital tract. Obstet Gynecol 101 (2003) 516-522
49. Kenyon S.L., Taylor D.J., Tarnow-Mordi W., and ORACLE Collaborative Group. Broad-spectrum antibiotics for spontaneous preterm labour: the ORACLE II randomised trial. Lancet 357 (2001) 989-994
50. McClean H. Impact of metronidazole therapy on preterm birth in women with bacterial vaginosis flora (Gardnerella vaginalis): a randomised, placebo controlled trial. Br J Obstet Gynaecol 104 (1997) 1391-1397
51. Carey J.C., Klebanoff M.A., Hauth J.C., et al. Metronidazole to prevent preterm delivery in pregnant women with asymptomatic bacterial vaginosis. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. N Engl J Med 342 (2000) 534-540
52. Ugwumadu A., Manyonda I., Reid F., and Hay P. Effect of early oral clindamycin on late miscarriage and preterm delivery in asymptomatic woman with abnormal vaginal flora and bacterial vaginosis: a randomized-controlled trial. Lancet 361 (2003) 983-988
53. Klebanoff M.A., Hauth J.C., MacPherson C.A., et al., Network, National Institute for Child Health and Development Maternal-Fetal Medicine Units. Time course of the regression of asymptomatic bacterial vaginosis in pregnancy with and without treatment. Am J Obstet Gynecol 190 (2004) 363-370